
3 January 2022
Women may derive less benefit from combination immune checkpoint inhibitor (ICI) therapy for advanced melanoma than men, suggest study findings published in JAMA Network Open.
3 January 2022
13 December 2021
9 December 2021
6 December 2021
29 November 2021
19 November 2021